phase 1_completion
savePfizer Inc — PF-08046032 (Phase I Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Advanced Malignancy, Diffuse Large B-Cell Lymphoma, Head And Neck Squamous Cell Carcinoma (HNSC), Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), Lymphoma, Melanoma, Non-Small Cell Lung Cancer, Peripheral T-Cell Lymphomas (PTCL), Solid Tumor
Data sources
globaldata
Found something off?
same company · ±60 days · 6
- drug shortageClindamycin Phosphate Injection shortage — Pfizer Inc.Apr 22, 2026
- drug shortageDexmedetomidine Hydrochloride Injection shortage — Pfizer Inc.Apr 22, 2026
- drug shortagePalbociclib Capsule shortage — Pfizer Inc.Apr 22, 2026
- drug shortageMethylprednisolone Acetate Injection shortage — Pfizer Inc.Apr 22, 2026
- drug shortageMethotrexate Sodium Injection shortage — Hospira, Inc., a Pfizer CompanyApr 22, 2026
- drug shortagePenicillin G Benzathine Injection shortage — Pfizer Inc.Apr 17, 2026
comments(0)
5-min edit window · permanent after that